Free shipping on all orders over $ 500

Gemcabene

Cat. No. M21472
Gemcabene Structure
Synonym:

PD-72953

Size Price Availability Quantity
5mg USD 135  USD135 In stock
10mg USD 210  USD210 In stock
25mg USD 420  USD420 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Gemcabene (PD-72953) is a first-in-class PPARα agonist, lipid-lowering agent. It lowers density lipoprotein cholesterol (LDL-C), lowers triglycerides and increases high density lipoprotein cholesterol (HDL-C), and lowers the pro-inflammatory acute phase protein, C-reactive protein (CRP), showing anti-inflammatory activity.

Chemical Information
Molecular Weight 302.41
Formula C16H30O5
CAS Number 183293-82-5
Solubility (25°C) DMSO ≥ 60 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Smruti M Besekar, et al. Cureus. A Systematic Review of the Randomized Controlled Trials of Gemcabene and Its Therapeutic Uses

[2] Daniel Gaudet, et al. Am J Cardiol. Usefulness of Gemcabene in Homozygous Familial Hypercholesterolemia (from COBALT-1)

[3] Daniela Carmen Oniciu, et al. PLoS One. Gemcabene downregulates inflammatory, lipid-altering and cell-signaling genes in the STAM™ model of NASH

[4] Rai Ajit K Srivastava, et al. Mol Cell Biochem. Gemcabene, a first-in-class lipid-lowering agent in late-stage development, down-regulates acute-phase C-reactive protein via C/EBP-δ-mediated transcriptional mechanism

[5] Jaap W Mandema, et al. AAPS J. Model-based development of gemcabene, a new lipid-altering agent

Related Products
DiosMetin 7-O-β-D-Glucuronide

DiosMetin 7-O-β-D-Glucuronide is an antioxidant constituent in the fruits of Luffa cylindrical.

Bendazac L-Lysine

Bendazac L-Lysine is an aldose reductase (AR) inhibitor, which can be used to inhibit the activity of AR in the eye to prevent cataracts.

Ro5-3335

Ro5-3335 acts as an inhibitor of core binding factor (CBF) leukemia. Ro5-3335 is a RUNX1-CBFβ interaction inhibitor that represses RUNX1/CBFB-dependent transactivation.

Bendazac

Bendazac is an oxyacetic acid with anti-inflammatory, antinecrotic, choleretic and antilipidaemic properties. Bendazac acts by preventing protein denaturation.

Dexamethasone palmitate

Dexamethasone palmitate (DXP) is a proagent of Dexamethasone. Dexamethasone palmitate can be used for the research of inflammation.

  Catalog
Abmole Inhibitor Catalog




Keywords: Gemcabene, PD-72953 supplier, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.